Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ipilimumab in patients with melanoma and autoimmune disease.
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Home or away? Choosing a setting for a falls-prevention program for people with multiple sclerosis.
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis.
Relevance of quality of life assessment for multiple sclerosis patients with memory impairment.
Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice.
Is neuropsychological rehabilitation effective in multiple sclerosis?
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
Loss of Mobility and the Patient Burden of Multiple Sclerosis: Expert Opinion on Relevance to Daily Clinical Practice.
Endothelin-B Receptor Activation in Astrocytes Regulates the Rate of Oligodendrocyte Regeneration during Remyelination.
Isolated dysphagia due to aquaporin-4 autoimmunity.
Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory.
Thalamus pathology in multiple sclerosis: from biology to clinical application.
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.
Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.
Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Multiple sclerosis: Defect in peripheral B-cell tolerance identified in MS.
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.
Pages
« first
‹ previous
…
597
598
599
600
601
602
603
604
605
…
next ›
last »